C. Pratt

发表

High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography.

M. Verani, J. Mahmarian, L. Moyé, 1995, The American journal of cardiology.

Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.

N. Geller, G. Knatterud, C. Conti, 1997, Circulation.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

W. Rogers, G. Kay, J. Mahmarian, 1989, The New England journal of medicine.

Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man.

R. Roberts, C. Pratt, M. Perryman, 1987, Circulation.

Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Jeffrey L. Anderson, L. Cobb, E. Schron, 1999, Journal of the American College of Cardiology.

The relative tolerance of children and adults to anticancer drugs.

D. V. Von Hoff, R. Ungerleider, C. Pratt, 1981, Frontiers of radiation therapy and oncology.

Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial.

B. Chaitman, J. Mahmarian, L. Moyé, 1998, Circulation.

Design of a randomized, placebo-controlled multicenter trial on the long-term effects of intermittent transdermal nitroglycerin on left ventricular remodeling after acute myocardial infarction. Transdermal Nitroglycerin Investigators Group.

J. Mahmarian, L. Moyé, C. Pratt, 1998, The American journal of cardiology.

901–41 Preliminary Mortality Results from the Survival with Oral D-Sotalol (SWORD) Trial

A. Camm, P. Schwartz, B. Pitt, 1995 .

Cardiovascular safety of fexofenadine HCl

A. Brown, C. Pratt, D. Rampe, 1999, Clinical and Experimental Allergy.

Cardiovascular safety of fexofenadine HCl.

C. Pratt, J. Mason, T. Russell, 1999, The American journal of cardiology.

Assessed by Quantitative Thallium-201 Single-Photon Emission Computed Tomography

M. Verani, J. Mahmarian, M. K. Cocanougher, 2005 .

Silent Myocardial Ischemia in Patients With Coronary Artery Disease

J. Mahmarian, C. Pratt, 2005 .

Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography.

M. Verani, J. Mahmarian, M. K. Cocanougher, 1990, Circulation.

The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography.

M. Verani, J. Mahmarian, T. M. Boyce, 1991, Journal of the American College of Cardiology.

Predicting Antiarrhythmic Performance

C. Pratt, 1999, Journal of cardiovascular electrophysiology.

Can antiarrhythmic drugs survive survival trials?

A. Camm, A. Waldo, C. Pratt, 1998, American Journal of Cardiology.

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

P. Kowey, K. Ellenbogen, J. Reiffel, 2010, JAMA.

Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test.

A. Waldo, J. Anderson, C. Pratt, 1997, The American journal of cardiology.

Value of intravenous streptokinase in acute myocardial infarction.

C. Pratt, R. Roberts, 1984, International journal of cardiology.

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

A. Jaffe, G. Knatterud, I. Ockene, 1988 .

Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography.

M. Verani, J. Mahmarian, L. Moyé, 1991, Journal of the American College of Cardiology.

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials.

D. DeMets, J. McMurray, K. Swedberg, 2017, JACC. Heart failure.

Reduction -Term Ventricular Arrhythmia ii y Encrlapril in Heart Failure

S. Yusuf, M. Henzlova, J. Kostis, 1995 .

Mueller et al TIMI II Subgroup Analyses : Predictors of Early Events 1255 factors for early death in patients with AMI treated with thrombolytic therapy . The Thrombolysis in Myocardial Infarction ( TIMI ) phase

D. DeMets, V. Fuster, K. Mann, 2005 .

Chronic beta blockade therapy in patients after myocardial infarction.

R. Roberts, C. Pratt, R. Roberts, 1983, The American journal of cardiology.

Case report: Severe hypercalcemia mimicking ST-segment elevation myocardial infarction.

C. Pratt, R. Schutt, C. Barker, 2014, Methodist DeBakey cardiovascular journal.

Risk stratification after acute myocardial infarction: Is it time to reassess? Implications from the INSPIRE trial

J. Mahmarian, C. Pratt, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Central Clinical Research Issues in Electrophysiology: Report of the NASPE Committee

M. Ezekowitz, C. Tracy, M. Domanski, 2001, Pacing and clinical electrophysiology : PACE.

Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.

M. Verani, J. Mahmarian, L. Moyé, 1994, The American journal of cardiology.

Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.

M. Verani, J. Farmer, N. Kleiman, 1998, Circulation.

An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction.

L. Shaw, M. Henzlova, T. Ruddy, 2006, Journal of the American College of Cardiology.

Hyperthyroidism and Mortality

J. Mahmarian, C. Pratt, 2007 .

Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia.

M. Verani, N. Benowitz, S. Nagueh, 1997, Journal of the American College of Cardiology.

Analysis of the cilostazol safety database.

C. Pratt, Craig M. Pratt, 2001, The American journal of cardiology.

The Cardiac Arrhythmia Suppression Trial: Implications for Antiarrhythmic Drug Development

L. Moyé, C. Pratt, L. Moye, 1990, Journal of clinical pharmacology.

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

A. Jaffe, G. Knatterud, I. Ockene, 1988, Journal of the American College of Cardiology.

Asymptomatic Cardiac Ischemia Pilot study (ACIP)

A. Baker, P. Stone, L. McDaniel, 1992, The American journal of cardiology.

Quantification of infarct size by 201Tl single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates.

M. Verani, J. Mahmarian, R. Roberts, 1988, Circulation.

Prognostic significance of ventricular premature depolarizations measured 1 year after myocardial infarction in patients with early postinfarction asymptomatic ventricular arrhythmia.

J. Bigger, D. Roden, A. Waldo, 1992, Journal of the American College of Cardiology.

A personal view of the controversy regarding the use of calcium channel blockers in hypertension

C. Pratt, 1997 .

The Cardiac Arrhythmia Suppression Trial: background, interim results and implications.

L. Moyé, C. Pratt, L. Moye, 1990, The American journal of cardiology.

Application and interpretation of submaximal exercise testing and ambulatory ECG recordings in patients with acute myocardial infarction.

C. Pratt, R. O’Rourke, 1988, Chest.

Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.

M. Quiñones, R. Roberts, C. Pratt, 1986, Circulation.

Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.

A. A. Taylor, M. Quiñones, H. Kopelen, 1984, Circulation.

Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy: double-blind study.

C. Pratt, J. Geller, J. Albert, 1979, Urology.

The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.

A. Camm, P. Schwartz, H. Al-Khalidi, 2004, Journal of the American College of Cardiology.

Efficacy of beta adrenergic blockade in coronary heart disease: Propranolol in angina pectoris

E. Amsterdam, H. Olson, D. Mason, 1975 .

Impact of managed care on the treatment of atrial fibrillation.

C. Pratt, 1998, The American journal of cardiology.

Patterns of Medication Use in Patients With Heart Failure: A Report From the Registry of Studies of Left Ventricular Dysfunction (SOLVD)

S. Yusuf, J. Kostis, D. Weiner, 1995, Southern medical journal.

Efficacy and safety of moricizine in patients with congestive heart failure: a summary of the experience in the United States.

C. Pratt, P. Podrid, S. Mahler, 1990, American heart journal.

The ESVEM Trial: Electrophysiologic Study Versus Electrocardiographic Monitoring for Selection of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias

Jeffrey L. Anderson, J. Bigger, J. Mason, 1989, Circulation.

Ventricular Arrhythmias After Acute Myocardial Infarction: Consideration of Arrhythmia Frequency, Complexity and Variability in Assessing Risk of Sudden Cardiac Death

R. Roberts, C. Pratt, 1987 .

Spontaneous arrhythmia detected on ambulatory electrocardiographic recording lacks precision in predicting inducibility of ventricular tachycardia during electrophysiologic study.

C. Wyndham, C. Pratt, B. Thornton, 1987, Journal of the American College of Cardiology.

Ventricular Antiarrhythmic Effects of Beta‐Adrenergic Blocking Drugs: A Review of Mechanism and Clinical Studies

C. Pratt, E. Lichstein, 1982, Journal of clinical pharmacology.

A reduction in the correlation dimension of heartbeat intervals precedes imminent ventricular fibrillation in human subjects.

J E Skinner, J. E. Skinner, C. Pratt, 1993, American heart journal.

Effects of exercise training on left ventricular performance and myocardial perfusion in patients with coronary artery disease.

R. Miller, M. Verani, G. H. Hartung, 1981, The American journal of cardiology.

Quantitative adenosine 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction.

M. Verani, J. Mahmarian, S. Nishimura, 1993, Circulation.

Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.

M. Verani, J. Mahmarian, C. Pratt, 1994, Journal of the American College of Cardiology.

Demonstration of Training Effect During Chronic β‐adrenergic Blockade in Patients with Coronary Artery Disease

W. G. Squires, R. Miller, C. Pratt, 1981, Circulation.

Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial.

M. Verani, F. Tortoledo, A. Raizner, 1985, The American journal of cardiology.

Evaluation of Antiarrhythmic Drug Efficacy in Patients with an ICD:

G. Breithardt, R. Campbell, J. Bigger, 1999, Journal of cardiovascular electrophysiology.

Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction

C. Pratt, 1998 .

Avoiding interpretive pitfalls when assessing arrhythmia suppression after myocardial infarction: insights from the long-term observations of the placebo-treated patients in the Cardiac Arrhythmia Pilot Study (CAPS)

J. Myles, J. Coromilas, P. Théroux, 1991, Journal of the American College of Cardiology.

Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?

R. Campbell, A. Camm, J. Bigger, 1999, European heart journal.

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

Bertram Pitt, A. Camm, P. Schwartz, 1996, The Lancet.

All that glitters is not gold.

A. Waldo, C. Pratt, 2003, European heart journal.

ALIVE Trial: How Is This Trial Design Different?

C. Pratt, 2000 .

The azimilide post-infarct survival evaluation (ALIVE) trial.

A. Camm, C. Pratt, R. Karam, 1998, The American journal of cardiology.

Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.

W. Zoghbi, C. Pratt, J. Young, 1990, The American journal of cardiology.

Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.

M. Knoll, S. Butman, C. Pratt, 1987, The American journal of cardiology.

Procainamide, Quinidine, Disopyramide, Cibenzoline, Pirmenol — Efficacy in the Treatment of Ventricular Arrhythmias: Current Status and Controversies

C. Pratt, 1985 .

The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia

E. Vaughan, E. Stein, J. Imperato-McGinley, 1992 .

Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP)

B. Chaitman, G. Knatterud, C. Pepine, 1999 .

New strategies in cardiovascular disease management: Summary of round table discussion

J. Ménard, J. Cohn, D. Abernethy, 1997 .

A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.

J. Durand, I. Kobrin, C. Pratt, 2001, Chest.

Comparison of Medical and Surgical Mortality in a High Risk Subset of Coronary Patients with Extreme Degrees of Exercise-Induced Ischemia

C. Pratt, Richard R. Miller, 1980 .

Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.

E. Toft, D. Wyse, C. Torp-Pedersen, 2010, The American journal of cardiology.

New agents to prevent strokes in nonvalvular atrial fibrillation.

C. Pratt, D. Putney, 2012, Methodist DeBakey cardiovascular journal.

Lack of diurnal variation in the onset of non-Q wave infarction.

K. Schechtman, W. Boden, N. Kleiman, 1990, Circulation.

Comparison With Enzymatic Estimates

M. Verani, J. Mahmarian, R. Roberts, 2005 .

Hemodynamic effects of intravenous and oral sotalol.

M. Verani, J. Mahmarian, C. Pratt, 1990, The American journal of cardiology.

Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator.

S. Hohnloser, J. Brachmann, M. Borggrefe, 2005, American Journal of Cardiology.

Comparative elfect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use

M. Quiñones, James B. Young, H. Kopelen, 2005 .

Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator

S. Hohnloser, J. Brachmann, M. Borggrefe, 2004, Circulation.

Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.

M. Quiñones, M. Hession, B. Lown, 1987, The American journal of cardiology.

Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: documentation of efficacy and long-term safety.

R. Miller, M. Quiñones, D. Mason, 1983, American heart journal.

The Management of Q-Wave Versus Non-Q-Wave Infarction

R. Roberts, C. Pratt, 1987 .

Short‐ and long‐term therapy of mild essential hypertension with timolol

A. DeMaria, E. Amsterdam, D. Mason, 1981, Clinical pharmacology and therapeutics.

Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.

M. Verani, J. Mahmarian, C. Pratt, 1995, Journal of the American College of Cardiology.

Value of CACS compared with ETT and myocardial perfusion imaging for predicting long-term cardiac outcome in asymptomatic and symptomatic patients at low risk for coronary disease: clinical implications in a multimodality imaging world.

F. Nabi, J. Mahmarian, S. Chang, 2015, JACC. Cardiovascular imaging.

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

P. Ponikowski, A. Keren, J. Rouleau, 2008, The Lancet.

Evaluation of metoprolol in suppressing complex ventricular arrhythmias.

M. Quiñones, C. Pratt, J. Young, 1983, The American journal of cardiology.

Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators.

N. Geller, G. Knatterud, C. Pepine, 1997, The American journal of cardiology.

Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction.

M. Quiñones, M. Limacher, D. Shindler, 1996, The American journal of cardiology.

Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).

P. Kowey, D. Packer, R. Myerburg, 2010, The American journal of cardiology.

Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry).

P. Kowey, D. Packer, R. Myerburg, 2010, The American journal of cardiology.

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

E. Toft, P. Kowey, P. Schwartz, 2009, Circulation. Arrhythmia and electrophysiology.

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial

A. Camm, E. Toft, A. Camm, 2008, Circulation.

First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia.

P. Kowey, E. Prystowsky, D. Cannom, 2005, The American journal of cardiology.

Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study.

P. Kowey, K. Ellenbogen, J. Reiffel, 2009, American heart journal.

The cardiac arrhythmia suppression trial. Casting suppression in a different light.

L A Moyé, C. Pratt, C M Pratt, 1995, Circulation.

Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification

A. Camm, P. Schwartz, E. Sonnenblick, 2004, Circulation.

Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?

A. Camm, P. Schwartz, B. Pitt, 1998, The American journal of cardiology.

Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial.

F. Harrell, J. Ruskin, F. Messerli, 1990, The American journal of cardiology.

Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.

C. Pratt, D. Slymen, A. Hallstrom, 1987, The American journal of cardiology.

Coronary artery calcium scoring in the emergency department: identifying which patients with chest pain can be safely discharged home.

Leif E. Peterson, F. Nabi, J. Mahmarian, 2010, Annals of emergency medicine.

A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction.

L. Shaw, M. Henzlova, T. Ruddy, 2006, Journal of the American College of Cardiology.

Value of Early Adenosine Technetium-99 m estamibi Myocardial Perfusion Imaging n Identifying a Low-Risk Group for Early ospital Discharge After Acute Myocardial Infarction

L. Shaw, M. Henzlova, T. Ruddy, 2006 .

Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.

N. Geller, P. Stone, B. Chaitman, 1994, Journal of the American College of Cardiology.

Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia.

M. Quiñones, R. Roberts, C. Pratt, 1985, The American journal of cardiology.

The search for novel antiarrhythmic strategies

G. Breithardt, R. Campbell, A. Camm, 1998 .

Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias.

C. Pratt, 2005, Journal of the American College of Cardiology.

Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators.

M. Henzlova, J. Kostis, M. Gardner, 1995, The American journal of cardiology.

The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory Committee.

F. Messerli, D. Lowenthal, C. Leier, 1988, JAMA.

Bleeding complications following initiation of thrombolytic therapy for acute myocardial infarction: a comparison of helicopter-transported and nontransported patients.

R. Fromm, C. Pratt, R. Roberts, 1991, Annals of emergency medicine.

Quantitative Adenosine 201 T 1 Single-Photon Emission Computed Tomography for the Early Assessment of Patients Surviving Acute Myocardial Infarction

M. Verani, J. Mahmarian, S. Nishimura, 2005 .

Adenosine sestamibi spect post-infarction evaluation (inspire) trial: a randomized, prospective multicenter trial evaluating the role of adenosine tc-99m sestamibi spect for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction

L. Shaw, J. Mahmarian, C. Pratt, 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators.

P. Stone, B. Chaitman, G. Knatterud, 1995, Journal of the American College of Cardiology.

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

J. Ruskin, S. Ruberg, C. Pratt, 1996, American heart journal.

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.

C. Pratt, R. P. Hertz, W. Louv, 1994, The American journal of cardiology.

Hemodynamic Effects of Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist, in Patients With Class III to IV Congestive Heart Failure

D. Mann, James B. Young, J. Durand, 2001, Circulation.

Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia.

M. Verani, J. Mahmarian, Z. He, 2000, Circulation.

Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction.

K. Hess, D. Glaeser, C. Pratt, 1993, Journal of the American College of Cardiology.

Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).

N. Geller, P. Stone, J. Hill, 1996, The American journal of cardiology.

Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.

A. Camm, P. Schwartz, M. Borggrefe, 2006, Journal of the American College of Cardiology.

Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial).

A. Camm, P. Schwartz, B. Pitt, 1995, The American journal of cardiology.

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design.

J. Rouleau, B. Greenberg, James B. Young, 2007, The Canadian journal of cardiology.

Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction.

D. Kanon, M. Quiñones, W. Winters, 1984, Journal of the American College of Cardiology.

Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators.

C. Pepine, D. Miller, R. Steingart, 1997, Journal of the American College of Cardiology.

Relation Between Ambulatory Electrocardiographic Monitoring and Myocardial Perfusion Imaging to Detect Coronary Artery Disease and Myocardial Ischemia: An ACIP Ancillary Studyfn1fn1Support for electro cardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, Califo

C. Pepine, D. Miller, R. Steingart, 1997 .

Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot Data Bank Study).

N. Geller, P. Stone, J. Hill, 1996, The American journal of cardiology.

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.

M. Schoenfeld, J. Reiffel, C. Pratt, 1996, Circulation.

Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.

S. Hohnloser, P. Tchou, H. Al-Khalidi, 2006, European heart journal.

Prognostic value of adenosine Tl-201 myocardial perfusion imaging after acute myocardial infarction: Results of a prospective clinical trial

J. Mahmarian, C. Pratt, J. Wendt, 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Conventional heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation.

J. E. Skinner, K. Hess, A. Goldberger, 1993, Journal of the American College of Cardiology.

Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.

B. Lewis, K. Stangl, U. Elkayam, 2003, Journal of the American College of Cardiology.

The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk.

Leif E. Peterson, F. Nabi, J. Mahmarian, 2009, Journal of the American College of Cardiology.

Panel discussion: Craig M. Pratt, MD, Moderator

C. Pratt, 2005 .

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.

Craig Pratt, C. Grines, A. Iskandrian, 2003, Journal of the American College of Cardiology.

Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.

M. Josephson, R. Winkle, A. De Maria, 1987, The American journal of cardiology.

Maximal improvement in ventricular performance during rest and exercise in chronic severe cardiac failure by combined inotropic and vasodilator therapy compared to either modality alone

M. Quiñones, A. Waggoner, C. Pratt, 1981 .

Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris.

R. Miller, H. Olson, D. Mason, 1976, Clinical pharmacology and therapeutics.

Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial

S. Hohnloser, P. Kowey, H. Al-Khalidi, 2016 .

Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial.

S. Hohnloser, P. Kowey, H. Al-Khalidi, 2008, Journal of the American College of Cardiology.

The effect of hormonal therapy for prostate cancer on the electrocardiographic QT interval: phase 3 results following treatment with leuprolide and goserelin, alone or with bicalutamide, and the GnRH antagonist abarelix

C. Pratt, M. Garnick, M. Campion, 2004 .

Relationship of vegetations on echogram to the clinical course and systemic emboli in bacterial endocarditis

E. Amsterdam, D. Mason, A. Neumann, 1978 .

Silent myocardial ischemia in patients with coronary artery disease. Possible links with diastolic left ventricular dysfunction.

J. Mahmarian, C. Pratt, Craig M. Pratt, 1990, Circulation.

Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)

P. Stone, B. Chaitman, G. Knatterud, 1997, The American journal of cardiology.

Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP)

B. Chaitman, G. Knatterud, C. Pepine, 1985, Journal of cardiac surgery.

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease.

M. Proschan, P. Stone, B. Chaitman, 1996, Circulation.

RSD1235 for conversion of atrial fibrillation. The phase III atrial arrhythmia conversion trial

E. Toft, D. Wyse, C. Torp-Pedersen, 2005 .

217 Increase in the electrocardiographic QTC interval in men with prostate cancer undergoing androgen deprivation therapy: Results of three randomized controlled clinical studies

C. Pratt, M. Garnick, M. Campion, 2004 .

C. Pratt, M. Garnick, M. Campion, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).

D. Wyse, J. Champagne, G. O'hara, 2005, The American journal of cardiology.

Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.

H. Kennedy, D. Mason, C. Pratt, 1987, The American journal of cardiology.

Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.

C. Pratt, 1990, The American journal of cardiology.

Electrophysiologic effects of ethmozin in patients with ventricular tachycardia.

J. Griffin, C. Wyndham, C. Pratt, 1984, American heart journal.

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

R. Kleiger, M. Gheorghiade, M. B. Perryman, 1986, The New England journal of medicine.

Pure Class III Agents for Prevention of Sudden Cardiac Death

C. Pratt, 2003, Journal of cardiovascular electrophysiology.

Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).

D. Mark, B. Chaitman, G. Knatterud, 1999, The American journal of cardiology.

Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events.

R R Miller, R. Miller, M. Quiñones, 1983, Journal of the American College of Cardiology.

Exercise testing in women with chest pain. Are there additional exercise characteristics that predict true positive test results?

G. Divine, C. Pratt, J. Young, 1989, Chest.

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

K. Mann, J. Gore, L. Hillis, 1991, Annals of internal medicine.

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio.

J. Mahmarian, R. Roberts, R. Roberts, 1989, American heart journal.

Exercise stress testing in patients with angiographically normal coronary arteries: Similar frequency of false positive ischemic responses in males and females

A. DeMaria, R. Chin, Garrett Lee, 1978 .

Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location.

M. Verani, N. Kleiman, J. Mahmarian, 1988, The American journal of cardiology.

The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.

N. Geller, M. Proschan, R. McMahon, 1994, Journal of the American College of Cardiology.

Activation of the complement system by recombinant tissue plasminogen activator.

R. Bolli, W. Bennett, R. Roberts, 1987, Journal of the American College of Cardiology.

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.

M Huther, H L Greene, S Gottlieb, 1995, Journal of the American College of Cardiology.

Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.

M. Quiñones, H. Kopelen, R. Roberts, 1984, Circulation.